Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP357552.RAsPQ4iWQrs_Ti5xi9vgVPH6OkuPFRTaSGOhABmkrWtuc130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP357552.RAsPQ4iWQrs_Ti5xi9vgVPH6OkuPFRTaSGOhABmkrWtuc130_provenance.
• NP66825.RAlTNRev1DcdK21GDtQAdpOk-cB9Vzcg6v1OsZ51RiqhY130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP66825.RAlTNRev1DcdK21GDtQAdpOk-cB9Vzcg6v1OsZ51RiqhY130_provenance.
• NP526057.RAqkNs0CVb-Yjf-xWLQ8E2LZeUsJJD8shbnGQ0mS62WLY130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526057.RAqkNs0CVb-Yjf-xWLQ8E2LZeUsJJD8shbnGQ0mS62WLY130_provenance.
• NP317127.RAPuQLyhUoYH4FbP9AUQD608cmigg6Rs_SBLxN477WCvQ130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317127.RAPuQLyhUoYH4FbP9AUQD608cmigg6Rs_SBLxN477WCvQ130_provenance.
• NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_provenance.
• NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_provenance.
• NP940716.RAUywzwVfbJzKNSCUjOeYtT5toyP0PegXPXVnOcMgBSDo130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940716.RAUywzwVfbJzKNSCUjOeYtT5toyP0PegXPXVnOcMgBSDo130_provenance.
• assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP570400.RAVvwPEurVmtDVYXeukZ8Nd5X_rMZppOOFBOoZ2-4dv0s130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570400.RAVvwPEurVmtDVYXeukZ8Nd5X_rMZppOOFBOoZ2-4dv0s130_provenance.
• NP570407.RAUEYLHOi7ZNgd6Ye-Y2nQ02wmHkncblI9324sAvycMIg130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570407.RAUEYLHOi7ZNgd6Ye-Y2nQ02wmHkncblI9324sAvycMIg130_provenance.
• assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP577918.RAL1TkfYN3twYedKl34D6hdy6mITVgHN2L-Q3OhaTi-ZA130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577918.RAL1TkfYN3twYedKl34D6hdy6mITVgHN2L-Q3OhaTi-ZA130_provenance.
• NP577945.RAGWvnPrBGMQNCZBLSEhYYfR598oj_dxpLr-7XxEhNEpg130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577945.RAGWvnPrBGMQNCZBLSEhYYfR598oj_dxpLr-7XxEhNEpg130_provenance.
• NP570401.RAP0fmBr0pZ95bjIVBB3vtIZVrg35CL5fOYFK66IjdfHA130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570401.RAP0fmBr0pZ95bjIVBB3vtIZVrg35CL5fOYFK66IjdfHA130_provenance.
• NP570403.RAz-UkWG27XZHWfoC_wQot6vXVUiDR67WCNTCaUyqcvX8130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570403.RAz-UkWG27XZHWfoC_wQot6vXVUiDR67WCNTCaUyqcvX8130_provenance.